BMS Makes Dealmaking A Top Priority As Doubts About Growth Increase

Observers Fear New Drugs Will Not Fill LOE Gap

 
• By Mandy Jackson
  
Growth is top of mind for BMS as LOEs approach later this decade (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Scrip